SEARCH

SEARCH BY CITATION

References

  • Acar N, Chardigny JM, Bonhomme B, Almanza S, Doly M, Sebedio JL (2002). Long-term intake of trans (n−3) polyunsaturated fatty acids reduces the b-wave amplitude of electroretinograms in rats. J Nutr 132: 31513154.
  • Ackman RG (1981). Flame ionization detection applied to thin-layer chromatography on coated quartz rods. Methods Enzymol 72: 205252.
  • Al-Shabrawey M, Bartoli M, El-Remessy AB, Platt DH, Matragoon S, Behzadian MA et al. (2005). Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am J Pathol 167: 599607.
  • Austin PC, Mamdani MM (2005). Impact of the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22/Reversal of Atherosclerosis with Aggressive Lipid Lowering trials on trends in intensive versus moderate statin therapy in Ontario, Canada. Circulation 112: 12961300.
  • Bayorh MA, Ganafa AA, Eatman D, Walton M, Feuerstein GZ (2005). Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension. Am J Hypertens 18: 14961502.
  • Bellini G, Bocin E, Cosenzi A, Sacerdote A, Molino R, Solimano N et al. (1995). Oscillatory potentials of the electroretinogram in hypertensive patients. Hypertension 25: 839841.
  • Bhutto IA, Amemiya T (1997). Vascular changes in retinas of spontaneously hypertensive rats demonstrated by corrosion casts. Ophthalmic Res 29: 1223.
  • Block F, Schwarz M (1998). The b-wave of the electroretinogram as an index of retinal ischemia. Gen Pharmacol 30: 281287.
  • Borghi C, Prandin MG, Costa FV, Bacchelli S, Degli Esposti D, Ambrosioni E (2000). Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol 35: 549555.
  • Brosche T, Kral C, Summa JD, Platt D (1996). Effective lovastatin therapy in elderly hypercholesterolemic patients – an antioxidative impact? Arch Gerontol Geriatr 22: 207221.
  • Bui BV, Fortune B (2004). Ganglion cell contributions to the rat full-field electroretinogram. J Physiol 555: 153173.
  • Chemtob S, Hardy P, Abran D, Li DY, Peri K, Cuzzani O et al. (1995). Peroxide–cyclooxygenase interactions in postasphyxial changes in retinal and choroidal hemodynamics. J Appl Physiol 78: 20392046.
  • Cingolani C, Rogers B, Lu L, Kachi S, Shen J, Campochiaro PA (2006). Retinal degeneration from oxidative damage. Free Radic Biol Med 40: 660669.
  • Ciulla TA, Amador AG, Zinman B (2003). Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 26: 26532664.
  • Davignon J (2004). Beneficial cardiovascular pleiotropic effects of statins. Circulation 109: III39III43.
  • Doly M, Droy-Lefaix MT, Braquet P (1993). Retinal electrophysiology and retinotoxicity. In: Ferradini C, MD-L, Christen Y (eds). Advances in Ginkgo biloba Extract Research: Ginkgo biloba Extract (EGb 761) as a Free-Radical Scavenger. Paris, France, pp 6171.
  • Dosso AA, Leuenberger PM, Rungger-Brandle E (1999). Remodeling of retinal capillaries in the diabetic hypertensive rat. Invest Ophthalmol Vis Sci 40: 24052410.
  • Du Y, Miller CM, Kern TS (2003). Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 35: 14911499.
  • Engelmann B (2004). Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem Soc Trans 32: 147150.
  • Erdos B, Snipes JA, Tulbert CD, Katakam P, Miller AW, Busija DW (2006). Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production. Am J Physiol Heart Circ Physiol 290: H1264H1270.
  • Ferrier KE, Muhlmann MH, Baguet JP, Cameron JD, Jennings GL, Dart AM et al. (2002). Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol 39: 10201025.
  • Folch J, Lees M, Sloane Stanley GH (1957). A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497509.
  • Glorioso N, Troffa C, Filigheddu F, Dettori F, Soro A, Parpaglia PP et al. (1999). Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension 34: 12811286.
  • Grech E, Dodd N, Jackson M, Morrison W, Faragher E, Ramsdale D (1996). Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial ischemia. Am J Cardiol 77: 122127.
  • Griendling KK, Sorescu D, Ushio-Fukai M (2000). NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494501.
  • Halliwell B, Zhao K, Whiteman M (1999). Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic Res 31: 651669.
  • Hirose F, Kiryu J, Miyamoto K, Nishijima K, Miyahara S, Katsuta H et al. (2004). In vivo evaluation of retinal injury after transient ischemia in hypertensive rats. Hypertension 43: 10981102.
  • Ikeda K, Negishi H, Yamori Y (2003). Antioxidant nutrients and hypoxia/ischemia brain injury in rodents. Toxicology 189: 5561.
  • Jeffrey BG, Mitchell DC, Gibson RA, Neuringer M (2002). n−3 fatty acid deficiency alters recovery of the rod photoresponse in rhesus monkeys. Invest Ophthalmol Vis Sci 43: 28062814.
  • Klein R, Klein BE, Moss SE (1997). The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 95: 329348; discussion 348–350.
  • Ko ML, Peng PH, Ma MC, Ritch R, Chen CF (2005). Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radic Biol Med 39: 365373.
  • Kortuem K, Geiger LK, Levin LA (2000). Differential susceptibility of retinal ganglion cells to reactive oxygen species. Invest Ophthalmol Vis Sci 41: 31763182.
  • Luhmann UF, Lin J, Acar N, Lammel S, Feil S, Grimm C et al. (2005). Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature. Invest Ophthalmol Vis Sci 46: 33723382.
  • Machida S, Kondo M, Jamison JA, Khan NW, Kononen LT, Sugawara T et al. (2000). P23 H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci 41: 32003209.
  • McGwin Jr G, McNeal S, Owsley C, Girkin C, Epstein D, Lee PP (2004). Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol 122: 822826.
  • McGwin Jr G, Xie A, Owsley C (2005). The use of cholesterol-lowering medications and age-related macular degeneration. Ophthalmology 112: 488494.
  • Mooradian AD, Haas MJ, Batejko O, Hovsepyan M, Feman SS (2005). Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats. Diabetes 54: 29772982.
  • Moreno MC, Campanelli J, Sande P, Sanez DA, Keller Sarmiento MI, Rosenstein RE (2004). Retinal oxidative stress induced by high intraocular pressure. Free Radic Biol Med 37: 803812.
  • Niu SL, Mitchell DC, Lim SY, Wen ZM, Kim HY, Salem Jr N et al. (2004). Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n−3 fatty acid deficiency. J Biol Chem 279: 3109831104.
  • Otto A, Fontaine D, Fontaine J, Berkenboom G (2005). Rosuvastatin treatment protects against nitrate-induced oxidative stress. J Cardiovasc Pharmacol 46: 177184.
  • Oudot A, Martin C, Busseuil D, Vergely C, Demaison L, Rochette L (2006). NADPH oxidases are in part responsible for increased cardiovascular superoxide production during aging. Free Radic Biol Med 40: 22142222.
  • Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND (2003). Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41: 341346.
  • Rogers LJ, Bolden SW, Patrech AS, Ehrlich D (1993). Visual dysfunction in the spontaneously hypertensive rat. Physiol Behav 54: 903907.
  • Sagar S, Kallo IJ, Kaul N, Ganguly NK, Sharma BK (1992). Oxygen free radicals in essential hypertension. Mol Cell Biochem 111: 103108.
  • SanGiovanni JP, Chew EY (2005). The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 24: 87138.
  • Schiffrin EL, Park JB, Intengan HD, Touyz RM (2000). Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 101: 16531659.
  • Sen K, Misra A, Kumar A, Pandey RM (2002). Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Res Clin Pract 56: 111.
  • Sicard P, Lauzier B, Oudot A, Busseuil D, Collin B, Duvillard L et al. (2005). A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats. Arch Mal Coeur Vaiss 98: 804808.
  • Sicard P, Oudot A, Guilland JC, Moreau D, Vergely C, Rochette L (2006). Dissociation between vascular oxidative stress and cardiovascular function in Wistar Kyoto and spontaneously hypertensive rats. Vascul Pharmacol 45: 112121.
  • Susic D, Varagic J, Ahn J, Slama M, Frohlich ED (2003). Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models. J Am Coll Cardiol 42: 10911097.
  • Szabo ME, Droy-Lefaix MT, Doly M (1992). Modification of reperfusion-induced ionic imbalance by free radical scavengers in spontaneously hypertensive rat retina. Free Radic Biol Med 13: 609620.
  • Touyz RM (2004). Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44: 248252.
  • Tzekov R, Arden GB (1999). The electroretinogram in diabetic retinopathy. Surv Ophthalmol 44: 5360.
  • Wachtmeister L (1998). Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res 17: 485521.
  • Wilson HL, Schwartz DM, Bhatt HR, McCulloch CE, Duncan JL (2004). Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol 137: 615624.
  • Wong TY, McIntosh R (2005). Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull 73–74: 5770.
  • Yu T, Mitchell P, Berry G, Li W, Wang JJ (1998). Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 116: 8389.
  • Zoeller RA, Morand OH, Raetz CR (1988). A possible role for plasmalogens in protecting animal cells against photosensitized killing. J Biol Chem 263: 1159011596.